G
GRCE
Grace Therapeutics, Inc
3.590
-0.030-0.83%After Hours: 3.600 +0.010 +0.28%19:18 04/10 EDT
OPEN/PREV CLOSE3.630/3.620
TODAY RANGE3.450-3.770
VOL415.77K
MARKET CAP55.55M
52 WEEK RANGE1.750-5.18
AVG VOL (3M)407.24K
% TURNOVER2.69%
TURNOVER--
P/E (TTM)-9.9529
% RANGE8.47%
EPS(TTM)-0.3607
P/E(FORWARD)-0.5752
P/B0.8561
BVPS4.194
DIVIDEND--
P/S33.92
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP38.11M
SHARES OUTSTANDING15.47M
NEXT EARNINGS06/26-07/02
FREE FLOAT10.62M
LOT SIZE1
EX-DATE07/10/2023
News
Press Releases
Financial Reports
Profile
Benzinga·4d ago
12 Health Care Stocks Moving In Tuesday's Intraday Session
Reuters·03/19 12:01
Grace Therapeutics to present GTx-104 aSAH data at two medical conferences
Seeking Alpha·02/12 13:14
Grace Therapeutics GAAP EPS of -$0.14 beats by $0.14
Benzinga·02/12 13:11
Grace Therapeutics Q3 EPS $(0.14) Beats $(0.28) Estimate
TipRanks·02/12 13:08
Grace Therapeutics reports Q3 EPS (14c) vs (36c) last year
Dow Jones·02/12 13:00
Press Release: Grace Therapeutics Announces Third -3-
Reuters·02/12 12:32
Grace Therapeutics posts Q3 R&D expenses of USD 0.46 million
TipRanks·01/22 13:36
Ten new option listings and two option delistings on January 22nd
TipRanks·01/12 22:32
Grace Therapeutics Enhances Executive Severance and Change‑in‑Control Terms
Reuters·11/30/2025 21:55
Grace Therapeutics Unveils Data on Novel IV Nimodipine for Subarachnoid Hemorrhage
Same Industry
Name/Symbol
Change%
Price